This @ThePrintIndia explainer by S. Gupta implies that S. Korean patients retested positive after having cleared SARS-CoV-2, because they took an inaccurate antibody test the 2nd time. Incorrect. They retested positive with PCR http://shorturl.at/jUV39
Also, his statement that by giving the drug to many Indians as prophylaxis, "a large enough trial takes place" is wrong again. No! A trial takes place if you do a trial. Getting thousands of people to take the drug is not a trial.
Then he claims that two tablets once a week is not really a "trial drug" in the first place. Huh? So what the hell are these guys doing? https://clinicaltrials.gov/ct2/show/NCT04343677?cond=COVID-19&draw=5